Diltiazem Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Diltiazem Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status To Be Discontinued. The shortage was first posted on Jan 5, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-4350-03
- Dosage Form
- Injection
- Presentation
- Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)
- Initial Posting
- Jan 5, 2026